Eli Lilly has paused the phase III trial of its ACTIV-3 monoclonal antibody treatment for the coronavirus as a result of potential safety concerns. “Safety is of the utmost importance to Lilly. We are aware that, out of an abundance of caution, the ACTIV-3 independent data safety monitoring board (DSMB) has recommended a pause in enrollment,” said Lilly spokeswoman Molly McCully. All 21 of the Yourway depots around the world are GMP certified, providing assurance that all products will be handled to the highest standards of quality and regulatory compliance. Pallets are fully segregated by client and product type.